A phase I study of the novel, third generation epothilone ZK-EPO in patients with advanced solid tumors.

被引：0
|
作者：
Schmid, P
Kiewe, P
Kuehnhardt, D
Korfel, A
Lindemann, S
Giurescu, M
Reif, S
Thiel, E
Possinger, K
机构：
[1] Humboldt Univ, Berlin, Germany
[2] Schering AG, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：147S / 147S
页数：1
相关论文
共 50 条
  • [21] A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases
    Freedman, Rachel A.
    Bullitt, Elizabeth
    Sun, Lixian
    Gelman, Rebecca
    Harris, Gordon
    Ligibel, Jennifer A.
    Krop, Ian E.
    Partridge, Ann H.
    Eisenberg, Emily
    Winer, Eric P.
    Lin, Nancy U.
    CLINICAL BREAST CANCER, 2011, 11 (06) : 376 - 383
  • [22] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [23] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Phase I study of MEDI0639 in patients with advanced solid tumors.
    Falchook, Gerald Steven
    Dowlati, Afshin
    Naing, Aung
    Gribbin, Matthew Joseph
    Jenkins, David William
    Chang, Linda L.
    Lai, Dominic W.
    Smith, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.
    Papadopoulos, K
    Mendelson, D
    Preston, GG
    Lopez, AM
    Ricart, AD
    Schwartz, G
    Needle, MN
    Gordon, MS
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9116S - 9116S
  • [26] Phase I study of sequential sapacitabine and seliciclib in patients with advanced solid tumors.
    Shapiro, Geoffrey
    Kwak, Eunice Lee
    Cleary, James M.
    Tolaney, Sara
    Gandhi, Leena
    Clark, Jeffrey W.
    Wolanski, Andrew
    Frame, Sheelagh
    Rodig, Scott J.
    Chiao, Judy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors.
    Xu, Ruihua
    Li, Yuhong
    Ji, Jiao
    Qiu, Miaozhen
    Zhang, Yang
    Liu, Wenqin
    Tian, Xiaohong
    Li, Su
    Wang, Hengbang
    Wang, Fenghua
    Zhang, Dongsheng
    Wang, Feng
    Wang, Zhiqiang
    Luo, Huiyan
    Zou, Benyan
    Wang, De shen
    Ren, Chao
    Jin, Ying
    Zhai, Yifan
    Yang, Dajun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas
    Aghajanian, Carol
    Burris, Howard A., III
    Jones, Suzanne
    Spriggs, David R.
    Cohen, Marvin B.
    Peck, Ronald
    Sabbatini, Paul
    Hensley, Martee L.
    Greco, F. Anthony
    Dupont, Jakob
    O'Connor, Owen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (09) : 1082 - 1088
  • [29] Phase I study of regorafenib and sildenafil in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Gordon, Sarah W.
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Ryan, Alison A.
    Kmieciak, Maciej
    Dent, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Phase I study of pemetrexed and sorafenib in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Shafer, Danielle A.
    Roberts, John D.
    Geyer, Charles E.
    Dent, Paul
    Moran, Richard
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Wan, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345